- Lobbying
- csl AND behring
Lobbying Arrangements Results for 'Csl Behring'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Preserving Access to Orphan Drugs Act, H.R. 1128 |
CSL Behring
|
PATTON BOGGS LLP | |||
Details Education regarding H.R.6465-Preserving Life-saving Access to Specialty Medicines in America Act (PLASMA Act) Issues related to the Medicaid Drug Rebate Program proposed rule, gene therapies, and ... |
CSL Behring LLC
|
in-house lobbying | |||
Details Prescription Drug User Fee Act, Orphan Drug Tax Credit, Tax Reform Medicare reimbursement for home infusion services, International Trade, HR 1628 "The American Health Care Act of 2017", Senate Ame... |
Julia Grant
|
CSL Behring LLC | |||
Details Pharma fee and orphan drug exclusion |
CSL Behring
|
McGuireWoods Consulting (A Subsidiary of McGuireWoods LLP) | |||
Details Issues related to Medicare and Medicaid and Modernization Act of 2003 (Public Law 108-173). |
ZLB Behring LLC
Pharmaceutical Company |
Alston & Bird, LLP | |||
Details Implementation of the orphan drug exception from pharmaceutical fee. |
CSL BEHRING LLC (formerly ZLB Behring)
|
ALSTON & BIRD, LLP | |||
Details Legislation pertaining to orphan drugs Orphan drug tax exclusion in the Patient Protection and Affordable Care Act |
CSL Behring
|
Arent Fox LLP | |||
Details Issues related to immigration and healthcare. |
CSL Behring
|
FULCRUM PUBLIC AFFAIRS LLC | |||
Details Issues related to Rx pricing; Issues related to plasma and plasma derived therapies. Issues related to legislative and regulatory issues related to gene therapies for hemophilia B; Issues related t... |
CSL Behring
|
Forbes-Tate | |||
Details Issues related to gene therapy. Issues related to plasma therapies. H.R. 2666, the Medicaid VBPs for Patients (MVP) Act and issues related to value-based payment arrangements. Issues related to dru... |
CSL Behring LLC
|
THE NICKLES GROUP, LLC |